Two Different Composite Markers Predict Severity and Threshold Dose in Peanut Allergy - Sorbonne Université
Journal Articles Journal of Allergy and Clinical Immunology: In Practice Year : 2020

Two Different Composite Markers Predict Severity and Threshold Dose in Peanut Allergy

Abstract

What is already known about this topic? Peanut allergy is one of the most frequent causes of anaphylaxis in children with food allergies. Oral food challenge remains the gold standard to evaluate the threshold dose and severity of peanut allergy. What does this article add to our knowledge? This study reports the relevance of allergen-specific and noneallergen-specific basophil activation test parameters to determine the severity and threshold dose of a peanut-allergic reaction in children. How does this study impact current management guidelines? Introduction of these multivariable models in routine practice could avoid an oral food challenge in some children with peanut allergy. BACKGROUND: Safe and cost-effective biological surrogate markers to evaluate the severity and threshold dose of peanut allergy (PA) reactions during an oral food challenge (OFC) are lacking. OBJECTIVE: To evaluate biological markers associated with the severity and threshold dose of an allergic reaction during an OFC in a population of children with PA. METHODS: Demographic and biological parameters of children with peanut OFC and basophil activation test (BAT) results were collected. Patients were stratified into 2 severity groups (mild-to-moderate and severe) and 2 cumulative threshold dose groups: low (LCTG) £100 mg crushed peanut and high >100 mg. RESULTS: Among the 68 children included, there was a 96% concordance between the OFC and BAT result for the diagnosis of PA. Of the 56 children with a positive OFC and BAT to peanut (median age: 8.8 years), the severity of an allergic reaction and the cumulative threshold dose were not correlated (P [ .24). Higher Ara h 2especific IgE and FcεRI-positive control values were both associated with severe reactions to peanut. Combining these 2 markers led to a 92% sensitivity (84%-97%) and an 82% specificity (71%-89%) for severe
Fichier principal
Vignette du fichier
cottel.pdf (368.24 Ko) Télécharger le fichier
Origin Files produced by the author(s)

Dates and versions

hal-03009456 , version 1 (24-11-2020)

Identifiers

Cite

Nathalie Cottel, Sarah Saf, Mélisande Bourgoin-Heck, Nathalie Lambert, Flore Amat, et al.. Two Different Composite Markers Predict Severity and Threshold Dose in Peanut Allergy. Journal of Allergy and Clinical Immunology: In Practice, 2020, ⟨10.1016/j.jaip.2020.09.043⟩. ⟨hal-03009456⟩
72 View
219 Download

Altmetric

Share

More